z-logo
open-access-imgOpen Access
Improvements in lung function with umeclidinium/vilanterol versus fluticasone propionate/salmeterol in patients with moderate-to-severe COPD and infrequent exacerbations
Author(s) -
Sally Worsley,
Liz Hardaker,
James F. Donohue,
Alison Church,
Changqing Zhu
Publication year - 2021
Publication title -
unc libraries
Language(s) - English
DOI - 10.17615/9p1m-pz88
Subject(s) - fluticasone propionate , copd , medicine , salmeterol , lung function , fluticasone , anesthesia , lung , inhalation

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom